ABSTRACT
INTRODUCTION
The small-for-gestational-age (SGA) fetus is common, occurring in 3-10% of singleton pregnancies, depending on the definition used, and poses both diagnostic and management dilemmas 1, 2 . Although many measures have been proposed to identify SGA fetuses with growth restriction (FGR) and increased risk of adverse perinatal outcome (APO), none is optimal. The existence of 'early' and 'late' phenotypes, with early-onset diagnosed < 32 weeks and associated with more severe placental pathology, pre-eclampsia and earlier or more severe APO 3, 4 , increases the challenge of finding gestational-age-appropriate triage and monitoring tools. Three systematic reviews of umbilical artery (UA), middle cerebral artery (MCA) and ductus venosus (DV) Doppler in the prediction of APO found only moderate positive likelihood ratios, of 3.4, 2.8 and 4.2, respectively [5] [6] [7] .
In a recent study of SGA > 32 weeks, APO was predicted by any one of estimated fetal weight (EFW) < 3 rd centile, abnormal cerebroplacental ratio (CPR) and abnormal uterine artery Doppler 8 . However, the PORTO study 9 (a multicenter prospective study of 1116 SGA/FGR fetuses with average gestational age at delivery of 37.8 weeks) found that combining EFW < 10 th centile and abnormal UA Doppler was most predictive, although APO positive predictive value was low. Likewise, in the TRUFFLE study 10 (a randomized trial of infants who had had early-onset FGR and abnormal UA Doppler, with median gestational age at delivery of 30.7 weeks), combined use of late changes in DV Doppler and cardiotocography (CTG) to predict adverse outcome led to improved neurodevelopmental outcome at 2 years compared with combining early DV changes with CTG or using CTG alone; however, interpretation and application of these findings is clouded by the TRUFFLE study's unexpectedly low rates of poor neurodevelopmental outcome.
Therefore, additional measures are still sought to improve triage and the timing of delivery of SGA/FGR fetuses. The fetal myocardial performance index (MPI), a Doppler-derived global measure of fetal ventricular function that is relatively easy to acquire 11 , has been proposed for this purpose. Prior evidence is conflicting, with some single-center studies suggesting its clinical utility [12] [13] [14] [15] , while neither the PORTO study 16 nor a multicenter early-onset FGR study 17 found MPI to be of additional utility compared with 'routine' UA, MCA and DV Doppler.
The objectives of this study were, therefore, to assess the potential clinical utility of MPI in SGA/FGR fetuses in the situations in which it would most often be applied: (1) triaging of women referred to fetal medicine services for assessment and management of SGA/FGR; and (2) determination of the optimal timing of delivery in these cases.
METHODS
This was a cohort study of women recruited prospectively, following referral at 24-38 weeks' gestation to one of two study hospitals in metropolitan Sydney, in the period June 2012 to March 2015, for management of suspected SGA/FGR. All study subjects underwent ultrasound examination for the purposes of this research on at least one occasion, and a consenting subgroup with ongoing pregnancy were followed longitudinally with repeat ultrasound examinations (local human research ethics committee references 8/168 and 13/320). Inclusion criteria were: singleton pregnancy, maternal age 18 years or over, and: (1) EFW < 10 th centile at referral scan with or without abnormal UA Doppler (UA pulsatility index (PI) > 95 th centile and/or absent or reversed UA end-diastolic flow) or (2) EFW ≥ 10 th centile but abdominal circumference (AC) < 10 th centile and abnormal UA Doppler. The latter group was included as, despite their 'normal' EFW, these fetuses are at increased risk of APO and are monitored as such in clinical practice 18, 19 .
Exclusion criteria were: known aneuploidy, fetal cardiac anomaly, major/multiple congenital anomaly suggesting a syndromal cause for FGR, insufficient command of English or psychiatric illness precluding the patient giving informed consent, and unavailability of perinatal outcome data. For ease of comparison with findings of prior studies, we also excluded from final analysis fetuses with birth weight ≥ 10 th centile according to gender using Australian centiles 20 in which antenatal Doppler studies had been normal and delivery was not on fetal grounds. Because in clinical practice this is unknown prospectively, a supplementary analysis including these fetuses was performed to explore whether results would have been altered significantly by their inclusion. Fetuses with birth weight ≥ 10 th centile, but which had abnormal UA or MCA Doppler recorded in the week prior to birth, or which were delivered for fetal concerns (e.g. abnormal CTG, no interval growth) were not excluded, as these cases were considered likely to have true FGR 21, 22 . Controls from uncomplicated pregnancies participating in MPI reference interval studies at our unit were recruited contemporaneously in the period from May 2012 to December 2014 23 . Data from any of these fetuses found subsequently to have a birth weight < 10 th centile on population charts 20 were excluded from use in the final case-control matching.
Gestational age was calculated according to last menstrual period and confirmed by first-trimester ultrasound examination. All examinations were performed by one of two sonographers (A.H. and J.A.) using a Voluson E8 Expert (GE Medical Systems, Australia) or Voluson 730 (GE Medical Systems) ultrasound machine, equipped with a 3.5-7-MHz curvilinear transducer. Machine settings used for all MPI studies were: fastest Doppler sweep velocity (13.8-15 cm/s on Voluson E8 Expert 'speed 5' and 10 cm/s on Voluson 730); angle of insonation 0-15
• ;
Doppler gain low; wall motion filter 300 Hz 24 . Left MPI (LMPI) and right MPI (RMPI) views were obtained for each fetus, with the three clearest waveforms and valve clicks in which fetal heart rate was within the normal range (120-160 bpm) being measured and averaged. Time intervals were measured at the peak of the mitral and aortic valve (opening and closing) clicks for the left ventricle ( Figure 1 ) and at the peak of the tricuspid and pulmonary valve (opening and closing) clicks for the right ventricle ( Figure 2 ). MPI was calculated offline by a single operator (A.H.) as (ICT + IRT)/ET for LMPI and (a − b)/b for RMPI, where ICT is isovolumetric contraction time, IRT is isovolumetric relaxation time, ET is ejection time, a is isovolumetric or 'a' interval and b is ejection time or 'b' interval. Delta MPI (DMPI) was calculated as RMPI − LMPI 23 . At each initial ultrasound examination, we carried out routine assessment of fetal biometry, amniotic fluid index (AFI) and UA, MCA and DV Doppler using existing reference intervals [25] [26] [27] [28] . MPI was acquired and CPR multiples of the median (MoM) were also calculated 29 . Additionally, in SGA/FGR cases, a biophysical profile (BPP) was performed for those aged 26 weeks or greater 30 Demographic and obstetric factors known to influence fetal growth, including maternal age, body mass index (BMI), gravidity/parity, country of birth, smoking status and pregnancy comorbidities (including hypertension and diabetes) were recorded 19 . The perinatal outcome data collected were perinatal mortality, gestational age at birth, birth weight, any known major neonatal complication/congenital abnormality, mode of birth, Apgar scores, umbilical cord arterial and venous pH and base excess when available, special care or neonatal intensive care admission and total neonatal length of hospital stay.
Statistical analysis
Data analysis was performed using SPSS Statistics version 23 (IBM SPSS Statistics for Windows, IBM Corp, Armonk, NY, USA). LMPI, RMPI and DMPI results for cases at first MPI examination were compared with those of a local reference population 23 using Student's t-test, and Z-score comparison against our reference population was performed. For the cohort assessed longitudinally (those women who remained undelivered 3 days or more after their first MPI scan and who consented to longitudinal follow-up), repeated measures analysis of variance was performed to assess within-subject MPI differences 31 . We used MPI reference intervals rather than control values as the primary comparison for SGA/FGR case values because the study's overarching objective was to assess whether MPI is clinically useful in the assessment and/or management of suspected SGA/FGR, and, if MPI is to be used clinically on a routine basis, values will be compared against reference intervals rather than controls.
Additionally, to investigate whether, in SGA/FGR, there are more subtle changes in MPI than would be evident on broad comparison against a reference population, we age-matched, to within 2 gestational weeks, controls to cases at the time of their first MPI ultrasound examination. Two weeks was chosen because, while a positive correlation of MPI with gestational age has been identified, differences within 2 gestational weeks were negligible [32] [33] [34] . A paired-samples t-test was used to compare MPI values, other ultrasound values at first MPI ultrasound examination, maternal demographics (age, BMI, parity) and pregnancy outcome data (gestational age at birth, birth weight and birth-weight centile, cord blood gases, Apgar scores, length of nursery stay) between cases and controls. Exploratory SGA/FGR subgroup analysis, to assess for greater utility of MPI in those subgroups more likely to represent severe FGR or known to be at higher risk of poor perinatal outcome from prior studies 3, 9, 19 , was also performed as outlined in the results.
To explore the prediction of pregnancy outcome by MPI and other sonographic measures, we assessed the following correlations (Pearson's for parametric data, Spearman's for non-parametric data) using data from the time of the first ultrasound examination: (1) LMPI and its constituent time intervals, RMPI and its constituent time intervals and DMPI vs ultrasound measures (EFW, UA-PI, MCA-PI, MCA-PSV, CPR, DV-PI, AFI, BPP) and vs gestational age; (2) LMPI and its constituent time intervals, RMPI and its constituent time intervals and DMPI vs pregnancy outcome; (3) non-MPI ultrasound measures vs pregnancy outcome. Following Swinscow and Campbell 35 , strength of correlation was defined according to correlation coefficient as follows: 0-0.19, very weak; 0.2-0.39, weak; 0.4-0.59, moderate; 0.6-0.79, strong; 0.8-1.0, very strong, with positive coefficients indicating positive correlation and negative coefficients negative correlation. P < 0.05 was considered statistically significant.
If LMPI, RMPI and/or DMPI were found on univariate testing to show consistent, significant differences between cases and controls or the reference population, or to correlate with perinatal outcome, multivariate modeling incorporating other significant univariate predictors of pathology or perinatal outcome was planned.
Sample size calculation
Sample size calculations were based on LMPI because, at the time of commencing recruitment, our group had data from the local reference population for LMPI but not for RMPI or DMPI 33 . Sample size calculations were based on 90% power (at α = 0.05) to detect a 15% difference in mean LMPI (a potentially clinically important difference) in SGA/FGR cases compared with the reference population, assuming that the LMPI SD for the SGA/FGR subgroup would be twice that of the reference population. For this, we calculated that a sample size of 46 would be required.
RESULTS
We enrolled 60 suspected cases of SGA/FGR and 100 controls initially, with 52 cases and 52 gestationalage-matched controls included in the final analysis ( Figure 3 ). Their demographic, obstetric and pregnancy outcome data are shown in Table 1 . Case mothers were on average 4 years older than controls (P < 0.001) and more likely to have a medical comorbidity during pregnancy (60% vs 12%, P < 0.001), although the medical comorbidity rate in controls underestimated the true rate since those with a major pre-existing medical condition or pregnancy complication at the time of ultrasound were excluded. As expected in a true pathological cohort, the average gestational age at birth for the SGA/FGR cases was late preterm and the average birth weight was half that of controls (1.7 vs 3.4 kg, P < 0.001). Most case babies were delivered by Cesarean section (69% vs 21% controls, P < 0.001), and 82% required admission to a special care unit, with a median overall neonatal hospital stay of 27 days (compared with 2.5 days for controls, P < 0.001).
Cross-sectional data from the gestational-age-matched cases (n = 52) and controls (n = 52) at the time of the first MPI ultrasound examination are shown in Table 2 . Confirming a true pathological cohort, the EFW Z-score averaged -1.8 for cases, UA Doppler studies were abnormal in 20 (38%) cases and MCA Doppler studies were abnormal in 13 (25%). With respect to MPI,
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Figure 3
Flowchart summarizing inclusion of study population. EFW, estimated fetal weight; FGR, fetal growth restriction; MPI, myocardial performance index; SGA, small-for-gestational age.
however, LMPI was > 95 th centile in only 5/52 (10%) studies, RMPI in only 7/51 (14%) and DMPI in only 4/50 (8%). Although this was slightly greater compared with the local reference population (10% SGA/FGR cases vs 3% local reference with LMPI > 95 th centile, P = 0.04; 14% SGA/FGR vs 5% local reference with RMPI > 95 th centile, P = 0.03), there were no significant differences between mean values or Z-scores of overall LMPI, RMPI or DMPI for cases vs reference population. Additionally, the large degree of overlap between case and reference-population data (Figure 4) suggests that the minor differences noted (e.g. ET significantly lower in SGA/FGR) would not be of clinical utility. Inclusion of data from the four patients with EFW < 10 th centile but birth weight > 10 th centile did not change the direction or significance of results.
Similarly, gestational-age-matching cases and controls at the time of the first MPI ultrasound examination did not point to clinical utility of MPI in triaging of SGA/FGR cases ( Table 2) . Although cases were more likely to have RMPI > 95 th centile (14% vs 2%, P = 0.03) or < 5 th centile (12% vs 2%, P = 0.06) than controls, average LMPI, RMPI and DMPI did not differ between cases and controls, and there was a high degree of overlap in RMPI values between them. Additionally, MPI differences between cases and controls were modest compared with differences in routine Doppler studies (e.g. UA Doppler was abnormal in 38% of SGA/FGR cases vs 0% of controls, P < 0.001).
Exploratory subgroup testing did not suggest a role for MPI in identifying increasing severity of SGA/FGR. LMPI differed significantly between the < 3 rd centile and the 3 rd -10 th centile subgroups; however, LMPI was lower in the < 3 rd centile subgroup (0.44 vs 0.47, P = 0.02), rather than being higher as would be expected, and the absolute difference was < 10%. Statistical significance was not reached for differences in LMPI, RMPI or DMPI in early-onset (71 ultrasound examinations, 38 patients) vs late-onset (16 ultrasound examinations, 14 patients) cases, in cases with abnormal UA Doppler (34 ultrasound examinations, 20 patients) vs those with normal UA Doppler (53 ultrasound examinations, 30 patients) or in the small subgroup with cord arterial pH < 7.2 after non-labor Cesarean section (n = 5) vs the reference population.
Regarding the potential use of MPI in timing of delivery, 22 women were followed longitudinally. Their average LMPI (0.45 ± 0.07), RMPI (0.48 ± 1.0) and DMPI (0.03 ± 0.09) were similar to those of the overall cohort, as were birth outcomes. On repeated measures analysis, there was no significant intersubject difference for LMPI, RMPI or DMPI. Additionally, values for interscan MPI difference showed a wide, Gaussian distribution, suggesting that differences in values between scans were more likely to represent random measurement variation than a clinically meaningful progression. The subgroup examination of cases with MPI performed < 72 h prior to delivery (n = 20) vs the reference population (n = 270) had, as anticipated, more evidence of fetal compromise compared with the SGA/FGR cohort overall: in 13 (65%), UA Doppler was abnormal, in 11 (55%), MCA Doppler was abnormal, and in eight Data are given as mean ± SD, n (%) or median (interquartile range). *Some cases had more than one pregnancy comorbidity. †Special care nursery or neonatal intensive care. ‡Includes cholestasis (n = 3), asthma (n = 5), substance abuse/mental health history (n = 3), hypothyroidism (n = 3), recurrent urinary tract infection/pre-existing renal disease (n = 3), other (n = 4). §One SGA/FGR stillbirth: pre-eclampsia superimposed on severe early-onset FGR resulted in induction of labor on maternal grounds at 25 weeks' gestation, at a non-viable weight. ¶Birth weight 10 th -20 th centile for gestational age (GA) and gender 20 in all five cases; categorized as true FGR secondary to abnormal antenatal Doppler studies and/or lack of interval growth and/or major fetal concerns (e.g. abnormal cardiotocogram) as trigger for birth. **Renal calculi (n = 1), asthma (n = 1), subclinical hypothyroidism (n = 1).
(40%), DV Doppler was abnormal. However, there were no overall differences in LMPI, RMPI or DMPI vs the reference population to suggest any utility of MPI in this group.
On correlation testing, there was little evidence of increased MPI correlating with abnormalities in other ultrasound measures, either at diagnosis (n = 52) or at ultrasound examination < 72 h prior to delivery (n = 20). There was a weak negative correlation with AFI (i.e. increased MPI value in presence of decreased amniotic fluid) for LMPI (Pearson's r = -0.29, P = 0.04) at diagnosis. There was also a weak negative correlation between LMPI and UA-PI (r = -0.26, P = 0.04). Otherwise, there were no significant correlations between UA, MCA or DV Doppler and LMPI, RMPI or DMPI. As expected, there were strong positive correlations between birth weight and gestational age at birth as well as strong correlations between LMPI and its constituent time intervals and RMPI and its constituent time intervals.
Correlations at diagnosis of SGA/FGR between MPI, other routine sonographic measures and perinatal outcome (as measured by gestational age at birth, birth weight, cord arterial pH, 5-min Apgar score and length of neonatal hospital stay after birth) are shown in Tables 3  and 4 . As anticipated, there was a strong negative correlation between UA-PI and gestational age at birth (r = -0.66, P = 0.003) and birth weight (r = -0.67, P < 0.001) and a moderate positive correlation with length of nursery stay (r = 0.53, P < 0.001). Likewise, EFW at time of MPI ultrasound was positively correlated with gestational age at birth and birth weight, and ( Data are given as mean ± SD or n (%). *Defined as UA-PI > 95 th centile and/or absent or reversed end-diastolic flow. †Defined as MCA-PI < 5 th centile and/or MCA-PSV > 95 th centile. ‡Defined as CPR < 5 th centile. §n = 51: in one first SGA/FGR study difference between 'a' and 'b' heart rate > 10 bpm, so RMPI not calculated. ¶n = 50: in two first SGA/FGR studies no RMPI or difference between LHR and RHR > 10 bpm, so DMPI not calculated. † †n = 267 included in 5 th -95 th centile calculations (gestational weeks 17-38). **Included secondary to abnormal Doppler/abdominal circumference < 10 th centile/fetal concerns supportive of FGR diagnosis. AFI, amniotic fluid index; CPR, cerebroplacental ratio; DMPI, delta myocardial performance index; DV, ductus venosus; EFW, estimated fetal weight; ET, ejection time; GA, gestational age; ICT, isovolumetric contraction time; IRT, isovolumetric relaxation time; LMPI, left myocardial performance index; MCA, middle cerebral artery; PI, pulsatility index; PSV, peak systolic velocity; RI, resistance index; RMPI, right myocardial performance index; UA, umbilical artery. negatively correlated with neonatal length of hospital stay (Table 4) . Expected correlations with perinatal outcome were also seen for MCA-PI, CPR, DV-PI and BPP. However, there were no significant correlations between absolute LMPI, RMPI or DMPI and perinatal outcomes, or between LMPI, RMPI or DMPI > 95 th centile and perinatal outcome.
Given the lack of significant univariate differences in MPI vs reference population, and the lack of significant correlation of MPI with perinatal outcome measures, multivariate modeling was not performed.
DISCUSSION
In this prospective cohort of women presenting to fetal medicine services for investigation and management of SGA/FGR, clinical utility of MPI was not found. There were only minor differences in MPI amongst SGA/FGR cases in comparison to our reference population 23 and to gestational-age-matched controls and when divided into exploratory subgroups to examine for the effect of SGA/FGR severity on MPI. There was also no evidence of MPI correlating with perinatal outcome, showing utility in triaging cases at the time of first MPI ultrasound examination, or showing utility in longitudinal follow-up (although this subgroup was underpowered). In contrast, there were moderate to strong correlations of the established measures of EFW and UA Doppler with perinatal outcome, supporting that these measures have some predictive value in SGA/FGR.
A summary of prior studies investigating the use of MPI in SGA/FGR 9, [12] [13] [14] [15] [16] [17] [36] [37] [38] [39] [40] [41] [42] [43] is shown in Table S1 . Potential reasons why some studies suggest the utility of MPI, while others do not, include: (1) different subgroups of SGA/FGR selected for inclusion; (2) emphasis on statistical rather than clinical significance; (3) publication bias towards positive findings; and (4) variability of acquisition and measurement techniques.
Regarding the selection of patients for inclusion, our cohort was selected to address the question of whether, when assessing a fetus referred to maternal-fetal medicine services for suspected SGA/FGR, MPI is likely to be helpful in triage and/or monitoring. It therefore included a broad spectrum of early-and late-onset cases, as well as cases with more severe (EFW < 3 rd centile with or without abnormal UA Doppler) and those with less severe disease. Sonographic markers and perinatal outcome nevertheless indicated a true pathological cohort, with over 80% nursery admission rate and 35/52 (67%) having, at the time of first ultrasound examination, at least one of the three conditions suggested by PORTO (EFW < 3 rd centile, abnormal UA Doppler, abnormal CPR) as being most predictive of perinatal outcome in SGA/FGR 9, 44 . It remains possible that, in cohorts such as one including early-onset, severe FGR (similar to that of the TRUFFLE study 10 ), MPI might be helpful alongside other parameters to model timing of delivery. However, findings of both Cruz-Martinez et al. 39 and the PORTO study 16 suggest that such clinical utility is unlikely because, in cases in which MPI does become abnormal, this typically occurs before the appearance of other Doppler abnormalities. Certainly, our investigation of MPI use in SGA/FGR cases, which reflects our usual clinical practice, did not find a role for adding MPI to routine measures.
Regarding delineation between statistical and clinical significance, while our study did have some positive findings (for example, there were more RMPI/LMPI cases > 95 th centile in the study than in the reference population), the large overlap in MPI distribution between cases and controls means that this finding is not of clinical utility. Others, including Cruz-Lemini et al. 17 , Unterscheider et al. 16 and Perez-Cruz et al. 42 , also found Table S1 , including recent work of Bhorat et al. 15 , who found MPI to be 35% higher in FGR cases than in controls as well as higher MPI with worsening FGR, and Nassr et al. 14 , who found LMPI to correlate with pregnancy outcome. This may be an example of publication bias in operation, as studies with negative results are less likely to be published and have a longer lead time to publication 45, 46 . Although trial registries have lessened this issue for randomized trials, registration of observational studies is still voluntary and is only done in a minority, meaning that the existing literature on MPI in SGA/FGR is likely biased towards positive results [47] [48] [49] . It is of note that the only multicenter study on MPI in early FGR 17 found a MPI increase that was only modest, and not of clinical utility in comparison to UA and DV Doppler. Likewise, the PORTO study 16 of over 1100 later SGA/FGR cases found abnormal MPI in a small proportion compared with abnormal CPR and UA Doppler, with abnormal MPI often occurring several weeks prior to delivery and therefore of no apparent use for timing delivery. Our results are in line with those of both of these larger studies, suggesting that they are more likely to be a true representation than false negative.
Finally, conflicting results can arise from differences in technique. Given the appropriate correlation of LMPI and RMPI constituent intervals with LMPI and RMPI in this study (Table 3) , high MPI acquisition rate, and other ultrasound measures showing previously noted and expected correlations, both with each other and with perinatal outcome in SGA/FGR, lack of technical proficiency is unlikely to account for our negative findings. However, even using 'mod-MPI' 50 (as opposed to the original Tei index), differences of 10-25% can occur depending on machine settings used and when the valve-click measurements are made, and substantial overlap is noted between one research group's pathology results and another's reference interval 11 . Any further exploration of MPI should thus ideally be undertaken using one of the automation algorithms now available [51] [52] [53] , including our group's algorithm which is planned to be available online in the coming 12 months.
Strengths of our study include the prospective enrolment and all MPI calculations being performed by an experienced operator beyond the initial MPI learning curve. Weaknesses include the modest sample size (although comparable to prior single-unit studies (see Table S1 )) and, potentially, the pragmatic inclusion criteria and heterogeneous nature of recruited patients. However, as the principal purpose of the study was to examine for clinical utility of using MPI in SGA/FGR, we believe the cohort to be appropriate.
In conclusion, LMPI, RMPI and DMPI in a cohort of singleton SGA/FGR fetuses presenting to fetal medicine services for investigation and management did not show consistent, significant differences from either a reference population or gestational-age-matched controls. MPI did not demonstrate clinical utility in either triage or longitudinal follow-up of the SGA/FGR cohort. No evidence was found to suggest that using MPI in SGA/FGR is additive to existing methods of evaluation. In the context of prior literature, it seems unlikely that MPI will translate from a research tool to clinical management of SGA/FGR.
